TrialHuman vaccines & immunotherapeutics2024

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial.

Yajun Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.